|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 11-20-2004
NEW YORK (Reuters) - The recent Vioxx withdrawal and testimony from an FDA insider accusing the agency of failing to protect public health are fueling such heightened concern over drug safety that valuable medicines could be kept from patients, doctors said on Friday.
NEW YORK (Reuters Health) - Here's another reason to give thanks this holiday season: the succulent turkey, cranberry sauce and sweet potatoes included in many Thanksgiving day meals may not only look and taste good, but may also be good for you.
NEW YORK (Reuters Health) - A part of the brain involved in both drug craving and judgment appears to be smaller in cocaine addicts than in healthy people, researchers have found.
NEW YORK (Reuters Health) - The wrist is a better access spot than the groin for performing angioplasty in very elderly patients with heart disease, new research shows.
NEW YORK (Reuters Health) - Symptoms of osteoarthritis of the knee are eased more when acupuncture is added to treatment with the painkiller diclofenac, Spanish researchers report.
NEW YORK (Reuters Health) - Children who were bottle-fed or used pacifiers as babies are at risk of dental problems in preschool, a new study suggests.
NEW YORK (Reuters Health) - Depression and manic depression are associated with dementia, and the more often a patient is hospitalized for these mental illnesses the greater their risk, Danish researchers report.
NEW YORK (Reuters Health) - After undergoing knee reconstruction, therapy with a machine that puts the joint through continuous passive motion leads to improved flexion when added to conventional physical therapy, according to a review by Canadian researchers.
NEW YORK (Reuters Health) - In the US, many mothers who have "no indicated risk" for a difficult vaginal birth are having caesarean deliveries -- and the rate is rising year by year -- according to a report in the British Medical Journal.
UNITED NATIONS (Reuters) - A divided United Nations on Friday rejected a U.S.-led campaign to ban all cloning of human embryos, including for stem-cell research, as a General Assembly committee opted instead for a nonbinding declaration.
|
|
